A detailed history of William B. Walkup & Associates, Inc. transactions in Organon & Co. stock. As of the latest transaction made, William B. Walkup & Associates, Inc. holds 1,500 shares of OGN stock, worth $21,870. This represents 0.02% of its overall portfolio holdings.

Number of Shares
1,500
Previous 1,514 0.92%
Holding current value
$21,870
Previous $31.3 Million 8.44%
% of portfolio
0.02%
Previous 0.02%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$18.65 - $23.03 $261 - $322
-14 Reduced 0.92%
1,500 $28.7 Million
Q2 2024

Aug 15, 2024

BUY
$17.45 - $21.96 $26,419 - $33,247
1,514 New
1,514 $31.3 Million

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $3.71B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track William B. Walkup & Associates, Inc. Portfolio

Follow William B. Walkup & Associates, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of William B. Walkup & Associates, Inc., based on Form 13F filings with the SEC.

News

Stay updated on William B. Walkup & Associates, Inc. with notifications on news.